Proactive Safety Monitoring of Biosimilars: A Comprehensive Approach Combining Immunogenicity, Big Data, and Global Standards.

Naudiyal M, Pannu A, Gangotri S, Kumar U, Rao SK

Open source

DOI
10.2174/0115748871503065260901071735
Published
2026 Sep 18
Container
Reviews on recent clinical trials
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2174/0115748871503065260901071735,
  title = {Proactive Safety Monitoring of Biosimilars: A Comprehensive Approach Combining Immunogenicity, Big Data, and Global Standards.},
  author = {Naudiyal M and Pannu A and Gangotri S and Kumar U and Rao SK},
  year = {2026},
  journal = {Reviews on recent clinical trials},
  doi = {10.2174/0115748871503065260901071735},
  url = {https://doi.org/10.2174/0115748871503065260901071735}
}

RIS

TY  - JOUR
TI  - Proactive Safety Monitoring of Biosimilars: A Comprehensive Approach Combining Immunogenicity, Big Data, and Global Standards.
AU  - Naudiyal M
AU  - Pannu A
AU  - Gangotri S
AU  - Kumar U
AU  - Rao SK
PY  - 2026
JO  - Reviews on recent clinical trials
DO  - 10.2174/0115748871503065260901071735
UR  - https://doi.org/10.2174/0115748871503065260901071735
ER  - 

APA

M, N., A, P., S, G., U, K., & SK, R. (2026). Proactive Safety Monitoring of Biosimilars: A Comprehensive Approach Combining Immunogenicity, Big Data, and Global Standards.. Reviews on recent clinical trials. https://doi.org/10.2174/0115748871503065260901071735

Source records